Director: Stewart M. Patrick, Senior Fellow and Director of the International Institutions and Global Governance Program
September, 2013 - Present
The project on the global regulation of medicines consists of workshops and publications that explore and identify institutional design solutions to address regulatory challenges for medicines. The primary responsibility of medicines regulators is to ensure that medicines consumed by publics are safe and effective. Agencies accomplish this through the implementation and enforcement of public health standards. Today's pharmaceutical market, however, poses significant challenges for regulators because the market is global, segmented, diverse, and decentralized—in terms of both finished products and ingredients. As a result, the remit of public authorities extends well beyond domestic borders, requiring oversight of actors globally.
This project is made possible by the generous support of the Robina Foundation.
For more information on the David Rockefeller Studies Program, contact: